IIT Roorkee scientists identify novel biomarker for early breast and ovarian cancer detection

A study conducted by a team researchers from Indian Institute of Technology (IIT) Roorkee has reported the use of saliva for early detection of breast and ovarian cancers, as opposed to the traditional method of using blood samples. The study was published in the journal FASEB Bioadvances.

Making a breakthrough, the research team led by Kiran Ambatipudi from the Biotechnology Department at IIT Roorkee have identified certain proteins present in the saliva, which act as potential biomarkers indicative of breast and ovarian cancer metastasis.

Due to the heterogeneous and asymptomatic nature of breast and ovarian cancers, their early detection has been difficult using traditional methods such as mammography, blood flow patterns by color flow Doppler imaging and transvaginal ultrasound examination, due to high diagnostic costs and radiation exposure," Ambatipudi said.

Read also: Adding Ultrasound to Mammography does not improve breast cancer detection: JAMA

"Our attempt was to utilize saliva as a non-invasive sample source to identify specific protein biomarkers, which indicate breast & ovarian cancer metastasis.

This new non-invasive diagnostic technique detects specific protein biomarkers whos high levels are indicative of breast cancer and ovarian cancer metastasis. In patients who have undergone three cycles of chemotherapy, the salivary proteins can also act as an indicator of the patient's response to chemotherapy.

The team compared samples from healthy individuals against samples collected from stage IV breast and ovarian cancer patients and ovarian cancer patients who had undergone at least 3 cycles of neoadjuvant chemotherapy.

Although it is essential to clinically validate these proteins in a large cohort of subjects but the results of the present study serve as an initial step towards development of saliva-based clinical tests , he added.

Breast cancer and ovarian cancer are responsible for a whopping one-fifth of cancer-related deaths worldwide.

Read also: ACP guidance statement for screening of breast cancer in average-risk women

With inputs from PTI